Activation of c-Jun NH2-terminal kinase (JNK) signaling pathway is essential for the stimulation of hepatitis C virus (HCV) non-structural protein 3 (NS3)-mediated cell growth

Virology

Volumn 333, Issue 2, 2005, Pages 324-336

  Hassan, Mohamed ^a   Ghozlan, Hanan ^b   Abdel Kader, Ola ^c  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Alexandria University Faculty Of Science   (Egypt)

^c ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

Cell growth; HCC; HCV NS3; JNK; MAP kinase

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; DNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NON STRUCTURAL PROTEIN 4A; NONSTRUCTURAL PROTEIN 3; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL GROWTH; CELL STIMULATION; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

EID: 13844265988     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2005.01.008     Document Type: Article

References (54)

1. S. Ahmed, A. Rahman, A. Hasnain, V.M. Goldberg, and T.M. Haqqi Phenyl N-tert-butylnitrone down-regulates interleukin-1 beta-stimulated matrix metalloproteinase-13 gene expression in human chondrocytes: suppression of c-Jun NH2-terminal kinase, p38-mitogen-activated protein kinase and activating protein-1 J. Pharmacol. Exp. Ther. 305 2003 981 988
2. H.J. Alter, R.H. Purcell, J.W. Shih, J.C. Melpolder, M. Houghton, Q.L. Choo, and G. Kuo Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis N. Engl. J. Med. 321 1989 1494 1500
3. P. Angel, K. Hattori, T. Smeal, and M. Karin The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1 Cell 55 1988 875 885
4. K.L. Auer, J. Contessa, S. Brenz-Verca, L. Pirola, S. Rusconi, G. Cooper, A. Abo, M.P. Wymann, R.J. Davis, M. Birrer, and P. Dent The Ras/Rac1/Cdc42/SEK/JNK/c-Jun cascade is a key pathway by which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes Mol. Biol. Cell 9 1998 561 573
5. A. Behrens, W. Jochum, M. Sibilia, and E.F. Wagner Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation Oncogene 19 2000 2657 2663
6. B.L. Bennett, D.T. Sasaki, B.W. Murray, E.C. O'Leary, S.T. Sakata, W. Xu, J.C. Leisten, A. Motiwala, S. Pierce, Y. Satoh, S.S. Bhagwat, A.M. Manning, and D.W. Anderson SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase Proc. Natl. Acad. Sci. U.S.A. 98 2001 13681 13686
7. P. Borowski, M. Heiland, K. Oehlmann, B. Becker, L. Kornetzky, H. Feucht, and R. Laufs Non-structural protein 3 of hepatitis C virus inhibits phosphorylation mediated by cAMP-dependent protein kinase Eur. J. Biochem. 237 1996 611 618
8. F. Bost, R. McKay, M. Bost, O. Potapova, N.M. Dean, and D. Mercola The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells Mol. Cell. Biol. 19 1999 1938 1949
9. C. Botteron, and D. Dobbelaere AP-1 and ATF-2 are constitutively activated via the JNK pathway in Theileria parva-transformed T-cells Biochem. Biophys. Res. Commun. 246 1998 418 421
10. C. Caelles, J.M. Gonzalez-Sancho, and A. Munoz Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway Genes Dev. 11 1997 3351 3364
11. R.W. Chamberlain, N. Adams, A.A. Saeed, P. Simmonds, and R.M. Elliott Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East J. Gen. Virol. 78 1997 1341 1347
12. F. Chang, L.S. Steelman, J.T. Lee, J.G. Shelton, P.M. Navolanic, W.L. Blalock, R.A. Franklin, and J.A. McCubrey Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention Leukemia 17 2003 1263 1293
13. Q.L. Choo, G. Kuo, A.J. Weiner, L.R. Overby, D.W. Bradley, and M. Houghton Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome Science 244 1989 359 362
14. A. Erhardt, M. Hassan, T. Heintges, and D. Haussinger Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK, and p38 MAP kinases together with the MAP kinase phosphatase MKP-1 in a HepG2 Tet-Off cell line Virology 292 2002 272 284
15. T. Fujita, S. Ishido, S. Muramatsu, M. Itoh, and H. Hotta Suppression of actinomycin D-induced apoptosis by the NS3 protein of hepatitis C virus Biochem. Biophys. Res. Commun. 229 1996 825 831
16. M. Furione, L. Simoncini, M. Gatti, F. Baldanti, M. Grazia Revello, and G. Gerna HCV genotyping by three methods: analysis of discordant results based on sequencing J. Clin. Virol. 13 1999 121 130
17. A. Grakoui, R. Levis, R. Raju, H.V. Huang, and C.M. Rice A cis-acting mutation in the Sindbis virus junction region which affects subgenomic RNA synthesis J. Virol. 63 1989 5216 5227
18. Y.L. Guo, B. Kang, L.J. Yang, and J.R. Williamson Tumor necrosis factor-alpha and ceramide induce cell death through different mechanisms in rat mesangial cells Am. J. Physiol. 276 1999 390 397
19. N.M. Hamad, J.H. Elconin, A.E. Karnoub, W. Bai, J.N. Rich, R.T. Abraham, C.J. Der, and C.M. Counter Distinct requirements for Ras oncogenesis in human versus mouse cells Genes Dev. 16 2002 2045 2057
20. Z. Han, D.L. Boyle, L. Chang, B. Bennett, M. Karin, L. Yang, A.M. Manning, and G.S. Firestein c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis J. Clin. Invest. 108 2001 73 81
21. M. Hassan, H. Ghozlan, and O. Abdel-kader Activation of RB/E2F signalling pathway is required for the modulation of hepatitis C virus (HCV) core protein-induced cell growth in liver and non-liver cells Cell Signalling 16 2004 1375 1385
22. Q.Q. He, R.X. Cheng, Y. Sun, D.Y. Feng, Z.C. Chen, and H. Zheng Hepatocyte transformation and tumour development induced by hepatitis C virus NS3 c-terminal deleted protein World J. Gastroenterol. 9 2003 474 478
23. Z. Hong, E. Ferrari, J. Wright-Minogue, R. Chase, C. Risano, G. Seelig, C.G. Lee, and A.D. Kwong Enzymatic characterization of hepatitis C virus NS3/4A complexes expressed in mammalian cells by using the herpes simplex virus amplicon system J. Virol. 70 1996 4261 4428
24. T. Hunter 1001 protein kinases redux-towards 2000 Semin. Cell Biol. 5 1994 367 376
25. J. Kato, N. Kato, H. Yoshida, S.K. Ono-Nita, Y. Stiratori, and M. Omata Hepatitis C virus NS4A and NS4B proteins suppress translation in vivo J. Med. Virol. 66 2002 187 199
26. N.J. Kennedy, H.K. Sluss, S.N. Jones, D. Bar-Sagi, R.A. Flavell, and R.J. Davis Suppression of Ras-stimulated transformation by the JNK signal transduction pathway Genes Dev. 17 2003 629 637
27. D.W. Kim, Y. Gwack, J.H. Han, and J. Choe C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase activity Biochem. Biophys. Res. Commun. 215 1995 160 166
28. H.J. Kwun, E.Y. Jung, J.Y. Ahn, M.N. Lee, and K.L. Jang P53-dependent transcriptional repression of p21 (waf 1) by hepatitis C virus NS3 J. Gen. Virol. 82 2001 2235 2241
29. J.M. Lenczowski, L. Dominguez, A.M. Eder, L.B. King, C.M. Zacharchuk, and J.D. Ashwell Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis Mol. Cell Biol. 17 1997 170 181
30. S. Leppa, M. Eriksson, R. Saffrich, W. Ansorge, and D. Bohmann Complex functions of AP-1 transcription factors in differentiation and survival of PC12 cells Mol. Cell. Biol. 21 2001 4369 4378
31. A. Lgssiar, M. Hassan, P. Schott-ohly, N. Friesen, F. Nicolitti, W.L. Trepicchio, and H. Gleichmann Interleukin-11 inhibits NF-kappaB and AP-1 activation in islets and prevents diabetes induced with streptozotocin in mice Exp. Biol. Med. 229 2004 425 436
32. S. Lin, J.J. Li, M. Fujii, and D.X. Hou Rhein inhibits TPA-induced activator protein-1 activation and cell transformation by blocking the JNK-dependent pathway Int. J. Oncol. 22 2003 829 833
33. P. Maher How protein kinase C activation protects nerve cells from oxidative stress-induced cell death J. Neurosci. 21 2001 2929 2938
34. P. Neddermann, L. Tomei, C. Steinkuhler, P. Gallinari, A. Tramontano, and R. De Francesco The nonstructural proteins of the hepatitis C virus: structure and functions Biol. Chem. 378 1997 469 476
35. S. Ogata, R.H. Florese, M. Nagano-Fujii, R. Hidajat, L. Deng, Y. Ku, S. Yoon, T. Saito, S. Kawata, and H. Hotta Identification of hepatitis C virus (HCV) subtype 1b strains that are highly, or only weakly, associated with hepatocellular carcinoma on the basis of the secondary structure of an amino-terminal portion of the HCV NS3 protein J. Clin. Microbiol. 41 2003 2835 2841
36. J. Ostrowski, M. Woszczynski, P. Kowalczyk, L. Trzeciak, E. Hennig, and K. Bomsztyk Treatment of mice with EGF and orthovanadate activates cytoplasmic and nuclear MAPK, p70S6k, and p90rsk in the liver J. Hepatol. 32 2000 965 974
37. J. Pinkas, and P. Leder MEK1 signaling mediates transformation and metastasis of EpH4 mammary epithelial cells independent of an epithelial to mesenchymal transition Cancer Res. 62 2002 4781 4790
38. D. Sakamuro, T. Furukawa, and T. Takegami Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells J. Virol. 69 1995 3893 3896
39. E. Santolini, L. Pacini, C. Fipaldini, G. Migliaccio, and N. Monica The NS2 protein of hepatitis C virus is a transmembrane polypeptide J. Virol. 69 1995 7461 7471
40. J. Schulze zur Wiesch, H. Schmitz, E. Borowski, and P. Borowski The proteins of the Hepatitis C virus: their features and interactions with intracellular protein phosphorylation Arch. Virol. 148 2003 1247 1267
41. R.F. Schwabe, C.A. Bradham, T. Uehara, E. Hatano, B.L. Bennett, R. Schoonhoven, and D.A. Brenner c-Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration Hepatology 37 2003 824 832
42. E. Shaulian, and M. Karin AP-1 in cell proliferation and survival Oncogene 20 2001 2390 2400
43. E. Shaulian, and M. Karin AP-1 as a regulator of cell life and death Nat. Cell Biol. 5 2002 E131 E136
44. S. Siavoshian, J.D. Abraham, M.P. Kieny, and C. Schuster HCV core, NS3, NS5A and NS5B proteins modulate cell proliferation independently from p53 expression in hepatocarcinoma cell lines Arch. Virol. 149 2004 323 336
45. J.A. Suzich, J.K. Tamura, F. Palmer-Hill, P. Warrener, A. Grakoui, C.M. Rice, S.M. Feinstone, and M.S. Collett Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes J. Virol. 67 1993 6152 61528
46. A. Takamizawa, C. Mori, I. Fuke, S. Manabe, S. Murakami, J. Fujita, E. Onishi, T. Andoh, I. Yoshida, and H. Okayama Structure and organization of the hepatitis C virus genome isolated from human carriers J. Virol. 65 1991 1105 1113
47. Y. Takihara, Y. Matsuda, and J. Hara Role of the beta isoform of 14-3-3 proteins in cellular proliferation and oncogenic transformation Carcinogenesis 21 2000 2073 2077
48. T. Tanaka, N. Kato, M.J. Cho, and K. Shimotohno A novel sequence found at the 3′ terminus of hepatitis C virus genome Biochem. Biophys. Res. Commun. 215 1995 744 749
49. A. Todisco, Y. Takeuchi, J. Yamada, J.I. Sadoshima, and T. Yamada Molecular mechanisms for the growth factor action of gastrin Am. J. Physiol. 272 1997 G721 G726
50. H. van Dam, D. Wilhelm, I. Herr, A. Steffen, P. Herrlich, and P. Angel ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents EMBO J. 14 1995 1798 1811
51. J.M. Yang, R.Q. Wang, B.G. Bu, Z.C. Zhou, D.C. Fang, and Y.H. Luo Effect of HCV infection on expression of several cancer-associated gene products in HCC World J. Gastroenterol. 5 1999 25 27
52. S.H. Yang, C.G. Lee, C.W. Lee, E.J. Choi, S.K. Yoon, K.S. Ahn, and Y.C. Sung Hepatitis C virus core inhibits the Fas-mediated p38 mitogen activated kinase signaling pathway in hepatocytes Mol. Cell 13 2002 452 462
53. R. Zemel, S. Gerechet, H. Greif, L. Bachmatove, Y. Birk, A. Golan-Goldhirsh, M. Kunin, Y. Berdichevsky, I. Benhar, and R. Tur-Kaspa Cell transformation induced by hepatitis C virus NS3 serine protease J. Viral Hepatitis 8 2001 96 102
54. V. Zoumpourlis, P. Papassava, S. Linardopoulos, D. Gillespie, A. Balmain, and A. Pintzas High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model Oncogene 19 2000 4011 4021